Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu(®)): An open label, uncontrolled study

Tekijä Vinnemeier, Christof David, Fischer-Herr, Johanna, Meyer, Seetha, Liebig, Katja, Theeß, Wiebke, Burchard, Gerd-Dieter, Cramer, Jakob P
Julkaistu 2014

Clinical Trial to Evaluate the Safety and Immunogenicity of a Trivalent Surface Antigen Seasonal Influenza Vaccine Produced in Mammalian Cell Culture and Administered to Young and...

Tekijä Loebermann, Micha, Voss, Ulrich, Meyer, Seetha, Bosse, Dietrich, Fritzsche, Carlos, Klammt, Sebastian, Frimmel, Silvius, Riebold, Diana, Reisinger, Emil C.
Julkaistu 2013

A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine - Assessing the immunogenicity and safety in an open label, uncontrolled study

Tekijä Roggelin, Louise, Vinnemeier, Christof D, Meyer, Seetha, Witte, Kai, Marx, Lydia, Theeß, Wiebke, Burchard, Gerd D, Rolling, Thierry, Cramer, Jakob P
Julkaisussa Hum Vaccin Immunother (2015)